IL2RA and B-cell chronic lymphocytic leukemia: Both conventional CD4+CD25hiCD127-/lo and unconventional CD4+CD25-/loCD127- FoxP3+ Tregs exhibited lower intrinsic apoptotic rates in CLL patients versus controls (47).